We are live on ! Find out more
VRTX icon

Vertex Pharmaceuticals
VRTX

376 hedge funds and large institutions have $17.1B invested in Vertex Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 376 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $419M | Put options by funds: $287M

Holders
376
Holders Change
+376
Holders Change %
–
% of All Funds
12.27%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
376
Increased
–
Reduced
–
Closed
–
Calls
$419M
Puts
$287M
Net Calls
+$131M
Net Calls Change
+$131M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
151
Shell Asset Management
Netherlands
$5.3M +$4.87M +66,177 New
CFB
152
Cullen/Frost Bankers
Texas
$5.25M +$4.83M +65,537 New
BFIC
153
Bedell Frazier Investment Counselling
California
$5.1M +$4.85M +65,884 New
TAM
154
Tocqueville Asset Management
New York
$5.08M +$4.67M +63,406 New
CA
155
Commerzbank Aktiengesellschaft
Germany
$4.81M +$4.42M +60,084 New
SONJCPFA
156
State of New Jersey Common Pension Fund A
New Jersey
$4.79M +$4.42M +60,000 New
GIA
157
Gateway Investment Advisers
Ohio
$4.74M +$4.37M +59,291 New
Ohio Public Employees Retirement System (OPERS)
158
Ohio Public Employees Retirement System (OPERS)
Ohio
$4.72M +$4.35M +59,060 New
Canada Pension Plan Investment Board
159
Canada Pension Plan Investment Board
Ontario, Canada
$4.7M +$4.32M +58,684 New
Nisa Investment Advisors
160
Nisa Investment Advisors
Missouri
$4.5M +$4.14M +56,250 New
Balyasny Asset Management
161
Balyasny Asset Management
Illinois
$4.4M +$4.05M +55,000 New
CAM
162
Congress Asset Management
Massachusetts
$4.26M +$3.92M +53,222 New
Royal London Asset Management
163
Royal London Asset Management
United Kingdom
$4.2M +$3.84M +52,188 New
DCM
164
Dupont Capital Management
Delaware
$4.17M +$3.85M +52,232 New
1832 Asset Management
165
1832 Asset Management
Ontario, Canada
$4.06M +$3.75M +50,900 New
Mitsubishi UFJ Asset Management
166
Mitsubishi UFJ Asset Management
Japan
$3.79M +$3.5M +47,500 New
GLRA
167
Gerald L. Ray & Associates
Texas
$3.77M +$3.47M +47,070 New
OPERF
168
Oregon Public Employees Retirement Fund
Oregon
$3.76M +$3.46M +47,035 New
TIP
169
Torray Investment Partners
Maryland
$3.63M +$3.34M +45,372 New
HI
170
HBK Investments
Texas
$3.46M +$3.19M +43,307 New
GH
171
GAM Holding
Switzerland
$3.33M +$3.07M +41,695 New
Asset Management One
172
Asset Management One
Japan
$3.29M +$3.01M +40,831 New
IGIM
173
I.G. Investment Management
Manitoba, Canada
$3.21M +$2.96M +40,153 New
URS
174
Utah Retirement Systems
Utah
$3.18M +$2.93M +39,827 New
Natixis Advisors
175
Natixis Advisors
Massachusetts
$3.14M +$2.88M +39,163 New
5 6
7
8 9

VRTX Hedge Fund Activity: Q2 2013 in Review

376 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Vertex Pharmaceuticals (VRTX) for Q2 2013, worth a combined $17.1B.

Buyers outnumbered sellers: 376 funds opened new VRTX positions and 0 closed out — a net gain of 376 holders — while 0 added to existing stakes and 0 trimmed.

  • 376 institutional investors held Vertex Pharmaceuticals (VRTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.1B of Vertex Pharmaceuticals stock for Q2 2013.
  • 376 funds opened new Vertex Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +376 holders.

Based on aggregated 13F filings for Q2 2013.